tradingkey.logo
tradingkey.logo
Search

Lifecore Biomedical Inc

LFCR
Add to Watchlist
4.720USD
-0.010-0.21%
Close 08-14 16:00ETQuotes delayed by 15 min
177.93MMarket Cap
LossP/E TTM

More Details of Lifecore Biomedical Inc Company

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc Profile

Ticker SymbolLFCR
Company nameLifecore Biomedical Inc
IPO dateFeb 15, 1996
CEOJosephs (Paul)
Number of employees406
Security typeOrdinary Share
Fiscal year-endFeb 15
Address3515 Lyman Boulevard
CityCHASKA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55318
Phone19523684300
Websitehttps://www.lifecore.com/
Ticker SymbolLFCR
IPO dateFeb 15, 1996
CEOJosephs (Paul)

Company Executives of Lifecore Biomedical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--

FAQs

Who are the top five shareholders of Lifecore Biomedical Inc?

The top five shareholders of Lifecore Biomedical Inc are: Mr. Paul Josephs

How many institutions hold shares of Lifecore Biomedical Inc (LFCR)?

As of 2026Q1, 225 institutions hold shares of Lifecore Biomedical Inc, with a combined market value of approximately 30.56M, accounting for 81.48% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1031462.00.

What is the biggest source of revenue for Lifecore Biomedical Inc?

In 2026Q1, the Contract development and manufacturing organization ("CDMO") business generated the highest revenue for Lifecore Biomedical Inc, amounting to 17.81M and accounting for 64.53% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.